CNMD EBITDA Growth
Conmed Corp · EBITDA Growth
CNMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.77%period ending
CNMD TTM EBITDA YoY % (21.43% → -22.77%)
Year-over-year change
High-resolution chart · PNG
CNMD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.7691% | |
| -27.103% | |
| -33.769% | |
| -27.5153% | |
| 2.5004% | |
| 15.5735% | |
| 38.8224% | |
| 87.9565% | |
| 74.0732% | |
| 1,035.7592% | |
| 598.3238% | |
| 114.7847% | |
| 102.3552% | |
| -89.5029% | |
| -84.6303% | |
| -60.7768% | |
| -61.2617% | |
| 44.049% | |
| 51.6199% | |
| 39.5027% | |
| 52.2188% | |
| -18.2124% | |
| -19.1256% | |
| -16.3649% | |
| -13.501% | |
| 22.0659% | |
| 9.8724% | |
| 9.9928% | |
| -0.7683% | |
| -0.9828% | |
| 26.1891% | |
| 39.3773% | |
| 41.4071% | |
| 44.4703% | |
| -0.1911% | |
| -9.6524% | |
| -8.6989% | |
| -15.2852% | |
| 11.1842% | |
| 4.2278% | |
| 16.4701% | |
| 13.0745% | |
| -3.5181% | |
| 1.1148% | |
| -16.4166% | |
| -12.8478% | |
| -5.3711% | |
| -11.1328% | |
| -9.6962% | |
| -0.1769% | |
| 9.795% | |
| 294.3521% | |
| 300.7162% | |
| 167.8675% | |
| 90.2912% | |
| -73.0017% | |
| -71.8935% | |
| -60.0773% | |
| -47.2995% | |
| 12.2605% | |
| 27.9746% | |
| 39.5212% | |
| 51.4989% | |
| 33.5008% | |
| 9.7461% | |
| -14.9721% | |
| -29.1759% | |
| -25.5361% | |
| -20.7569% | |
| -6.4986% | |
| -2.9835% | |
| 238.4204% | |
| 213.7773% | |
| 201.1484% | |
| 424.3549% | |
| -57.4252% | |
| -58.0688% | |
| -62.6256% | |
| -81.8175% | |
| -26.041% | |
| -20.8683% | |
| -11.6242% | |
| 5.8248% | |
| -26.8398% | |
| -25.2588% | |
| -17.0666% | |
| -20.1226% | |
| 19.7842% | |
| 18.9483% | |
| -1.7421% | |
| 10.8043% | |
| -4.1269% | |
| -1.8446% | |
| 9.3031% | |
| 2.6366% | |
| 4.2658% | |
| 5.6777% | |
| 8.2003% | |
| 5.4869% | |
| 3.8994% |